Keywords
BiologyParadigm shiftNormalization (sociology)Cancer immunotherapyImmunotherapyComputational biologyCancerGeneticsEpistemologyAnthropology
Affiliated Institutions
Related Publications
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
We introduce quanTIseq, a method to quantify the fractions of ten immune cell types from bulk RNA-sequencing data. quanTIseq was extensively validated in blood and tumor samples...
The future of immune checkpoint therapy
Immune checkpoint therapy, which targets regulatory pathways in T cells to enhance antitumor immune responses, has led to important clinical advances and provided a new weapon a...
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
Immune escape is a prerequisite for tumor development. To avoid the immune system, tumors develop different mechanisms, including T cell exhaustion, which is characterized by ex...
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
Abstract Anti-tumour immune activation by checkpoint inhibitors leads to durable responses in a variety of cancers, but combination approaches are required to extend this benefi...
Cancer immunotherapy using checkpoint blockade
The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses i...
Publication Info
- Year
- 2018
- Type
- review
- Volume
- 175
- Issue
- 2
- Pages
- 313-326
- Citations
- 1381
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1381
OpenAlex
Cite This
Miguel F. Sanmamed,
Lieping Chen
(2018).
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization.
Cell
, 175
(2)
, 313-326.
https://doi.org/10.1016/j.cell.2018.09.035
Identifiers
- DOI
- 10.1016/j.cell.2018.09.035